CQDM AI 1st Webinar: The Evolving Landscape of AI Implementation in New Drug Discovery & Development

In the first event of the series Philip Tagari, VP of Research (Therapeutic Discovery), Amgen hosted a panel of leading pharmaceutical and artificial intelligence executives to discuss the topic:

Using Machine Learning on Publicly Available Biomedical Data for Target Discovery

With the participation of
• Pierre Fitzgibbon (Minister of Economy and Innovation - Gouvernement du Québec)
• Marie-Paule Jeansonne (CEO of Forum IA Québec)
Panelists:
• Sarah Jenna (CEO, My Intelligent Machines (MIMs))
• Morten Sogaard , Ph.D (VP and Head, Target Sciences, Pfizer)
• Kimberly Powell, (VP / GM, Healthcare at NVIDIA)
• Yoshua Bengio (Scientific Director - Mila / Professor - U. of Montreal)